NXGL
NXGL
NASDAQ · Health Care

Nexgel Inc

$0.52
+0.00 (+0.44%)
As of Jun 29, 10:38 PM ET ·
Financial Highlights (FY 2026)
Revenue
17.17M
Net Income
-4,511,512
Gross Margin
39.5%
Profit Margin
-26.3%
Rev Growth
+77.3%
D/E Ratio
0.20
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 39.5% 39.5% 62.3% 62.3%
Operating Margin -27.9% -25.1% 15.0% 15.7%
Profit Margin -26.3% -25.0% 11.4% 15.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 17.17M 9.69M 5.33M 4.69M
Gross Profit 6.78M 3.82M 3.32M 2.92M
Operating Income -4,796,495 -2,435,043 798.7K 735.9K
Net Income -4,511,512 -2,290,365 604.4K 705.4K
Gross Margin 39.5% 39.5% 62.3% 62.3%
Operating Margin -27.9% -25.1% 15.0% 15.7%
Profit Margin -26.3% -25.0% 11.4% 15.0%
Rev Growth +77.3% +77.3% +6.5% +7.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 513.2K 513.2K 6.23M 5.69M
Total Equity 2.56M 2.56M 8.36M 7.17M
D/E Ratio 0.20 0.20 0.75 0.79
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -3,683,614 -1,973,958 1.03M 893.3K
Free Cash Flow 660.3K 478.5K